Applied DNA Sciences

Stony Brook, United States Founded: 1983 • Age: 43 yrs Listed
Botanical-DNA-based security and authentication solutions are developed.

About Applied DNA Sciences

Applied DNA Sciences is a publicly listed company based in Stony Brook (United States) founded in 1983. Botanical-DNA-based security and authentication solutions are developed. It operates on a Professional Services model. The company has 48 employees. Applied DNA Sciences has completed 2 acquisitions, including Spindle Biotech and Vandalia Research. Its Indian entity Applied Dna Sciences India Private Limited reported revenue of β‚Ή2.1 Lakh. Applied DNA Sciences offers products and services including lineaDNAβ„’. Its focus areas include Biotechnology, Genetic Medicine and DNA-Based Therapeutics. Its competitors include DDC Paternity Tests, Othram and IntegenX; 2 of its 3 listed competitors have raised funding.

Company details

Applied DNA Sciences is engaged in the development and manufacture of DNA-based technologies for genetic medicine. Expertise in polymerase chain reaction (PCR) and enzymatic DNA synthesis is utilized to design and commercialize lineaDNA. This technology is applied in mRNA production, gene therapy, and cell therapy. The companys solutions are aimed at advancing therapeutic modalities within the biotechnology sector.

  • Headquarters Stony Brook, United States
  • Employees 48
  • Stage Public
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website adnas.com
  • Social LinkedIn X Facebook
  • Legal Name Applied Dna Sciences, Inc.
Key Metrics
  • Indian entity revenue
    ₹2.1 Lakh

    FY 2025 · -97% YoY

  • Indian entity net loss
    -₹37.6 Lakh

    FY 2025 · -1806% margin

  • Indian entity EBITDA
    -₹37 Lakh

    FY 2025 · -1780% margin

  • Latest Funding Round
    $58M (USD), Post-IPO

    Sep 2025

  • Investors
  • Employee Count
    48
  • Investments & Acquisitions

Products & Services of Applied DNA Sciences

Applied DNA Sciences offers a comprehensive portfolio of products and services, including lineaDNA™.

lineaDNA™
Therapeutic DNA Production

DNA technology used for mRNA and gene therapy.

Funding Insights of Applied DNA Sciences

  • Total Rounds 17
  • Last Round Post-IPO β€” $58M
  • First Round $5.48M

    (Jan 2005)

  • Investors Count 2

Latest 10 of 17 funding rounds of Applied DNA Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2025$58MPost-IPO––
–
Oct 2020$1.2MPost-IPO––
–
Jun 2020$40,000Grant––
Aug 2019$418,000Post-IPO––
–
Jul 2019$1.5MPost-IPO––
Sep 2018$1.65MPost-IPO––
–
Jun 2017$805,000Post-IPO––
–
Nov 2016$5MPost-IPO––
–
Jun 2014$2.15MPost-IPO––
–
Aug 2013$7.5MPost-IPO––
–
Valuation history

2 investors in total: 2 institutional.

Investors in Applied DNA Sciences

Applied DNA Sciences has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include National Grid and Dillon Hill Capital.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Limited information is provided about Dillon Hill Capital.
dillonhillcapital.com
Electricity and gas transmission and distribution services are provided.
1990nationalgrid.comLondon, United Kingdom
Premium access

Investor details for Applied DNA Sciences

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Applied Dna Sciences India Private Limited (Applied DNA Sciences)

Applied Dna Sciences India Private Limited is the primary company behind Applied DNA Sciences. The board of Applied Dna Sciences India Private Limited currently have 2 directors; the longest-serving is Beth Margaret Jantzen, appointed in 2017. 7 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Beth Margaret Jantzen
DIN 07759303
Director22 Jun 20179 yrs 4 moApplied Dna Sciences India Private Limited
Mihir Pravinbhai Vaghela
DIN 08493153
Director27 Jun 20197 yrs 4 moApplied Dna Sciences India Private Limited

People of Applied DNA Sciences

25 people are tracked at Applied DNA Sciences (9 in leadership, 7 in board & advisors, 9 in team); the tracked headcount is 48.

NameRoleGroup
Jane Chan
Director Customer OperationsLeadership
Wayne Buchen
VP Strategic SalesLeadership
Tom Ackerman
Executive Director, Information TechnologyLeadership
Nafeez Zia, MA, MBA, ASQ-CSSGB
Director, Quality Assurance and ComplianceLeadership
Patricia Sobolewski ASQ CQA, CMQ/OE
Associate Director Quality SystemsLeadership
Aaron Chung
Director, Nucleic Acid PlatformsLeadership
Judy Murrah
COOLeadership
Dominick Avento III
Executive Director, Quality Assurance and ComplianceLeadership
Brian Viscount
Vice President Biopharma and DNA productionLeadership
Bob Catell
DirectorBoard & advisors
Yacov Shamash
DirectorBoard & advisors
Scott Anchin
DirectorBoard & advisors
Sanford R. Simon
DirectorBoard & advisors
John Bitzer III
DirectorBoard & advisors
Joseph Ceccoli
DirectorBoard & advisors
Elizabeth Schmalz Ferguson
DirectorBoard & advisors
Jess Hayward
Project Manager/Systems IntegratorTeam
Frank Cipriani
Production ManagerTeam
Dr. Ashok Kumar Chauhan (PhD)
Senior ScientistTeam
Carlie Victor, MLS(ASCP)CM
Lead TechnologistTeam

5 more people are available in the full profile.

Premium access

Complete people profiles for Applied DNA Sciences

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Applied DNA Sciences

Applied DNA Sciences is a publicly listed company on the NASDAQ with ticker symbol APDN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date28 Jul 2003
  • Listed onNASDAQ: APDN
  • Listed entityApplied DNA Sciences, Inc.
  • Exchange sectorHealth technology
  • Share price$4.14 (+42.27% on the day) · 2025-09-29
  • Market capitalisation$5.3M
  • EPS (diluted, trailing year)$-921.84
  • Volume (last session)7,983,562
  • Analyst consensusNeutral

Financials of Applied DNA Sciences

Figures of Applied Dna Sciences India Private Limited, the primary company behind Applied DNA Sciences, for FY 2025. Revenue was ₹2.1 Lakh (-97% year on year). Net loss was -₹37.6 Lakh (-1806% margin). EBITDA was -₹37 Lakh (-1780% margin). Revenue has grown at a compounded annual rate of -72% over three years and -54% over five years.

  • ₹2.1 LakhRevenue · FY 2025 · -97% YoY
  • -₹37.6 LakhNet loss · -1806% margin
  • -₹37 LakhEBITDA · -1780% margin
  • ₹1.45 CrPaid-up capital
  • -72%Revenue CAGR, 3 years
  • -54%Revenue CAGR, 5 years
Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2024$3.4M-$7.0M-$13.3M
2023$13.4M-$9.9M-$9.6M
2022$18.2M-$8.3M-$12.7M
2021$9.0M-$14.3M-$11.4M
2020$1.9M-$13.0M-$12.2M

Balance sheet, profit and loss, cash flow and ratios of Applied Dna Sciences India Private Limited are on its company page.

Premium access

Detailed financial statements for Applied DNA Sciences

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Applied DNA Sciences

Applied DNA Sciences has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Spindle Biotech and Vandalia Research.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Gene editing research tools are provided using synthetic RNA.
spindle.bioToronto, Canada2016Jul 2023β€’β€’β€’β€’
Customized DNA sequences are manufactured through scaled-up PCR processes.
vandaliaresearch.comHuntington, United States2004Sep 2015$1.5M
Premium access

Complete acquisition details for Applied DNA Sciences

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Applied DNA Sciences

6 dated milestones of Applied DNA Sciences across 42 years, from founding to its latest funding, stage changes and deals.

  1. Founded Applied DNA Sciences is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Funding First funding round of $5.5M.
  4. Acquisition Acquires Vandalia Research.
  5. Acquisition Acquires Spindle Biotech.
  6. Funding Latest funding round, Post-IPO, of $58.0M.

Competitors of Applied DNA Sciences

Applied DNA Sciences has 3 listed competitors in our database, 2 of them funded. They include DDC Paternity Tests, Othram and IntegenX.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
dnacenter.com1995Fairfield, United States
DNA tests and personalized diagnostics are provided for various specialties.
othram.com2018Houston, United States$33.16M22
Genomic services are provided for forensic investigations and research.
integenx.com2006Pleasanton, United States$92.06M78
Instruments for rapid human DNA identification are developed.
Premium access

Detailed competitors of Applied DNA Sciences

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Applied DNA Sciences

The website of Applied DNA Sciences (adnas.com) receives about 6.5K visits a month.

  • Monthly visits
    6.5K

    ▲ 14.5% vs previous month

Similar websites

Websites whose visitors overlap most with Applied DNA Sciences. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
trutags.com
70%
View details

Top companies in Genomics & Gene Therapy Platforms

3 companies that operate in the same segment as Applied DNA Sciences (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Applied Dna Sciences

Premium access

Complete news archive for Applied DNA Sciences

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Applied DNA Sciences

Applied DNA Sciences was founded in 1983 and raised its 1st funding round 22 years after it was founded.

Applied DNA Sciences is headquartered in Stony Brook, United States. It is registered at Stony Brook, New York, United States.

Applied DNA Sciences has 48 employees.

The primary company behind Applied DNA Sciences, Applied Dna Sciences India Private Limited, reported revenue of β‚Ή2.1 Lakh for FY 2025, down 97% year on year.

Applied DNA Sciences is engaged in the development and manufacture of DNA-based technologies for genetic medicine. Expertise in polymerase chain reaction (PCR) and enzymatic DNA synthesis is utilized to design and commercialize lineaDNA. This technology is applied in mRNA production, gene therapy, and cell therapy. The companys solutions are aimed at advancing therapeutic modalities within the biotechnology sector.

Applied DNA Sciences's top competitors include DDC Paternity Tests, IntegenX and Othram.

Applied DNA Sciences offers lineaDNAβ„’.

Yes, Applied DNA Sciences is publicly traded on NASDAQ under the ticker symbol APDN.

Applied DNA Sciences has made 2 acquisitions, including Spindle Biotech, and Vandalia Research.

Applied DNA Sciences has 2 investors. Key investors include National Grid, and Dillon Hill Capital.

Applied DNA Sciences operates through Applied Dna Sciences India Private Limited.

The legal entities of Applied DNA Sciences currently have 2 directors, including Mihir Pravinbhai Vaghela, Beth Margaret Jantzen.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available